Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Gemcitabine and Docetaxel in Elderly NSCLC
NCT00905983Phase 2Unknown
- Sponsor
- Hospital Universitari Arnau de Vilanova
- Start
- Oct 2007
- Primary completion
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of gemcitabine, docetaxel in non-small cell lung cancer (NSCLC), sponsored by Hospital Universitari Arnau de Vilanova. Status: unknown.
02
Drugs
gemcitabinedocetaxel
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00905983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00905983.